Olimel N5e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N5e provides amino acid supplementation that supports the metabolic pathway of protein synthesis and nitrogen balance in several clinical contexts.

• Post‑operative recovery: helps maintain nitrogen balance and supports tissue repair.
• Chronic kidney disease: assists in managing protein‑energy wasting when dietary intake is insufficient.
• Severe burns or trauma: contributes to increased protein requirements for wound healing.
• Inborn errors of metabolism: supplies missing amino acids in specific metabolic disorders.
• Long‑term parenteral nutrition: serves as a component of amino acid mixtures for patients on home or hospital‑based PN.

• The amino acids in Olimel N5e act as substrates for protein synthesis, providing essential building blocks for cellular structures, enzymes and neurotransmitters. By replenishing circulating pools of both essential and non‑essential amino acids, the formulation supports nitrogen balance, stimulates mTOR signaling pathways and aids in tissue repair and metabolic homeostasis.

Adverse reactions are generally mild and related to the oral or parenteral route of administration.

Common Side Effects

• Nausea: transient discomfort after ingestion.
• Abdominal discomfort: mild cramping or bloating.
• Diarrhoea: loose stools, usually self‑limiting.
• Metallic taste: temporary alteration of taste perception.
• Injection site erythema (if administered intravenously): mild redness.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling or anaphylaxis.
• Hyperammonemia: elevated blood ammonia in patients with severe liver dysfunction.
• Metabolic acidosis: rare disturbance of acid‑base balance.
• Hyperuricemia: increased uric acid levels, potentially precipitating gout.
• Severe electrolyte imbalance: uncommon shifts in potassium or calcium levels.

When prescribing Olimel N5e, clinicians should consider patient‑specific factors and monitor relevant clinical parameters.

• Renal impairment: adjust dosage and monitor nitrogen waste products.
• Hepatic dysfunction: watch for signs of hyperammonemia.
• Pregnancy and lactation: evaluate risk‑benefit, as safety data are limited.
• Concomitant nutrition therapy: avoid excessive total protein intake.
• Pediatric use: dose must be calculated by weight and age.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Amino acid mixtures can influence the absorption and metabolism of several drugs.

Major Interactions (Avoid)

• Levodopa: reduced central availability due to competition for transport.
• Anticonvulsants (e.g., phenobarbital): increased catabolism of amino acids.

Moderate Interactions (Monitor Closely)

• Thyroid hormones: altered serum protein binding.
• Warfarin: potential fluctuation in INR due to changes in plasma protein levels.
• Insulin: enhanced glucose uptake may modify insulin requirements.
• Diuretics: risk of electrolyte shifts when combined with high amino‑acid loads.
• Oral contraceptives: possible reduction in plasma albumin affecting drug levels.